Patents by Inventor Brooke Baggett

Brooke Baggett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR INCREASING ENERGY METABOLISM
    Publication number: 20200338078
    Abstract: Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions comprise a combination of a PDE 5 inhibitor, such as sildenafil or icariin, and resveratrol, and a branched amino acid such as leucine, or its metabolite.
    Type: Application
    Filed: April 8, 2020
    Publication date: October 29, 2020
    Inventors: Michael Zemel, Antje Bruckbauer, Brooke Baggett
  • Compositions and methods for increasing energy metabolism
    Patent number: 10646489
    Abstract: Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions comprise a combination of a PDE 5 inhibitor, such as sildenafil or icariin, and resveratrol, and a branched amino acid such as leucine, or its metabolite.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: May 12, 2020
    Assignee: NuSirt Sciences, Inc.
    Inventors: Michael Zemel, Antje Bruckbauer, Brooke Baggett
  • COMPOSITIONS AND METHODS FOR INCREASING ENERGY METABOLISM
    Publication number: 20180235970
    Abstract: Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions comprise a combination of a PDE 5 inhibitor, such as sildenafil or icariin, and resveratrol, and a branched amino acid such as leucine, or its metabolite.
    Type: Application
    Filed: February 7, 2018
    Publication date: August 23, 2018
    Inventors: Michael Zemel, Antje Bruckbauer, Brooke Baggett
  • Compositions, method, and kits for treating pulmonary conditions
    Patent number: 10039733
    Abstract: Compositions, methods, and kits useful for treating pulmonary conditions are provided herein. Such compositions can contain synergizing amounts of a non-specific phosphodiesterase inhibitor, such as a methylxanthine, in combination with leucine and/or a leucine metabolite, and resveratrol.
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: August 7, 2018
    Assignee: NuSirt Sciences, Inc.
    Inventors: Michael Zemel, Brooke Baggett, Antje Bruckbauer
  • Compositions and methods for increasing energy metabolism
    Patent number: 9943517
    Abstract: Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions comprise a combination of a PDE 5 inhibitor, such as sildenafil or icariin, and resveratrol, and a branched amino acid such as leucine, or its metabolite.
    Type: Grant
    Filed: November 13, 2013
    Date of Patent: April 17, 2018
    Assignee: NuSirt Sciences, Inc.
    Inventors: Michael Zemel, Antje Bruckbauer, Brooke Baggett
  • COMPOSITIONS, METHOD, AND KITS FOR TREATING PULMONARY CONDITIONS
    Publication number: 20170368012
    Abstract: Compositions, methods, and kits useful for treating pulmonary conditions are provided herein. Such compositions can contain synergizing amounts of a non-specific phosphodiesterase inhibitor, such as a methylxanthine, in combination with leucine and/or a leucine metabolite, and resveratrol.
    Type: Application
    Filed: July 11, 2017
    Publication date: December 28, 2017
    Inventors: Michael Zemel, Brooke Baggett, Antje Bruckbauer
  • Compositions, method, and kits for treating pulmonary conditions
    Patent number: 9737501
    Abstract: Compositions, methods, and kits useful for treating pulmonary conditions are provided herein. Such compositions can contain synergizing amounts of a non-specific phosphodiesterase inhibitor, such as a methylxanthine, in combination with leucine and/or a leucine metabolite, and resveratrol.
    Type: Grant
    Filed: July 23, 2014
    Date of Patent: August 22, 2017
    Assignee: NuSirt Sciences, Inc.
    Inventors: Michael Zemel, Brooke Baggett, Antje Bruckbauer
  • COMPOSITIONS AND METHODS FOR INCREASING ENERGY METABOLISM
    Publication number: 20160279130
    Abstract: Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions comprise a combination of a PDE 5 inhibitor, such as sildenafil or icariin, and resveratrol, and a branched amino acid such as leucine, or its metabolite.
    Type: Application
    Filed: November 13, 2013
    Publication date: September 29, 2016
    Inventors: Michael ZEMEL, Antje BRUCKBAUER, Brooke BAGGETT
  • TREATING PULMONARY CONDITIONS
    Publication number: 20150359771
    Abstract: Compositions, methods, and kits useful for treating pulmonary conditions are provided herein. Such compositions can contain synergizing amounts of a non-specific phosphodiesterase inhibitor, such as a methylxanthine, in combination with leucine and/or a leucine metabolite, and resveratrol.
    Type: Application
    Filed: January 14, 2014
    Publication date: December 17, 2015
    Inventors: Michael ZEMEL, Antje BRUCKBAUER, Brooke BAGGETT
  • COMPOSITIONS, METHOD, AND KITS FOR TREATING PULMONARY CONDITIONS
    Publication number: 20150018375
    Abstract: Compositions, methods, and kits useful for treating pulmonary conditions are provided herein. Such compositions can contain synergizing amounts of a non-specific phosphodiesterase inhibitor, such as a methylxanthine, in combination with leucine and/or a leucine metabolite, and resveratrol.
    Type: Application
    Filed: July 23, 2014
    Publication date: January 15, 2015
    Inventors: Michael Zemel, Brooke Baggett, Antje Bruckbauer